Pharmacokinetics of Sugammadex Dosed by Actual and Ideal Body Weight in Patients With Morbid Obesity Undergoing Surgery
This analysis of a published study (NCT03346070) evaluated the pharmacokinetics (PKs) of sugammadex dosed by actual body weight (ABW) or ideal body weight (IBW) for reversal of moderate or deep neuromuscular block (M‐NMB or D‐NMB) in adults with morbid obesity. Adults with body mass index ≥ 40 kg/m2...
Saved in:
Main Authors: | Kate Mostoller (Author), Rebecca Wrishko (Author), Lata Maganti (Author), W. Joseph Herring (Author), Mariëlle vanZutphen‐van Geffen (Author) |
---|---|
Format: | Book |
Published: |
Wiley,
2021-03-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Sugammadex and recurarization in an infant.
by: J. Arends, et al.
Published: (2020) -
Cardiovascular adverse effects of sugammadex
by: Mukul Chandra Kapoor
Published: (2020) -
Reversal of rocuronium‐induced intense neuromuscular blockade by sugammadex in Korean children: A pharmacokinetic and pharmacodynamic analysis
by: Sang‐Hwan Ji, et al.
Published: (2023) -
Conventional reversal of rocuronium-induced neuromuscular blockade by sugammadex in Korean children: pharmacokinetics, efficacy, and safety analyses
by: Sang-Hwan Ji, et al.
Published: (2023) -
Sugammadex and anaphylaxis: An analysis of 33 published cases
by: Baris Arslan, et al.
Published: (2021)